Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $6.6600 (-15.7%) ($6.5000 - $7.7500) on Wed. May. 13, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 34.05% (three month average) | RSI | 87 | Latest Price | $6.6600(-15.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.4% a day on average for past five trading days. | Weekly Trend | CAPR advances 32.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) XOP(34%) OIH(33%) DIA(29%) XLE(29%) IVE(27%) | Factors Impacting CAPR price | CAPR will decline at least -17.025% in a week (0% probabilities). VIXM(-25%) VXX(-23%) TLT(-19%) UUP(-15%) BND(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -17.025% (StdDev 34.05%) | Hourly BBV | 0 () | Intraday Trend | -12.4% | | | |
|
5 Day Moving Average | $7.37(-9.63%) | 10 Day Moving Average | $7.21(-7.63%) | 20 Day Moving Average | $5.06(31.62%) | To recent high | -21.6% | To recent low | 0% | Market Cap | $131m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |